Resources Connection, Inc. (RECN) At $16.65 Forms Top; 12 Analysts Bullish Adamas Pharmaceuticals, Inc. (ADMS)

Resources Connection, Inc. (NASDAQ:RECN) Logo

Among 13 analysts covering Adamas Pharmaceuticals (NASDAQ:ADMS), 12 have Buy rating, 1 Sell and 0 Hold. Therefore 92% are positive. Adamas Pharmaceuticals had 36 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) has “Outperform” rating given on Thursday, December 24 by Credit Suisse. Mizuho maintained Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) rating on Friday, March 9. Mizuho has “Buy” rating and $49.0 target. Noble Financial maintained Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) on Wednesday, November 8 with “Buy” rating. The rating was upgraded by Mizuho to “Buy” on Thursday, June 16. The rating was maintained by Cowen & Co with “Buy” on Wednesday, August 9. The rating was maintained by Piper Jaffray with “Buy” on Thursday, February 22. Mizuho maintained it with “Buy” rating and $26.0 target in Friday, August 25 report. The firm has “Neutral” rating given on Thursday, May 12 by Mizuho. The rating was maintained by JMP Securities on Friday, August 25 with “Market Outperform”. The company was initiated on Wednesday, April 4 by Leerink Swann. See Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) latest ratings:

19/04/2018 Broker: Mizuho Rating: Buy New Target: $49.0000 Maintain
04/04/2018 Broker: Leerink Swann Rating: Buy New Target: $31.0000 Initiate
27/03/2018 Broker: Bank of America Rating: Buy New Target: $39 Initiates Coverage On
09/03/2018 Broker: Mizuho Rating: Buy New Target: $49.0 Maintain
22/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $49.0 Maintain
23/02/2018 Broker: Needham Rating: Buy New Target: $40.0 Maintain
20/02/2018 Broker: Evercore Rating: Buy New Target: $85.0 Maintain
20/02/2018 Broker: Mizuho Rating: Buy New Target: $48.0 Maintain
30/01/2018 Broker: Piper Jaffray Rating: Buy New Target: $55.0 Maintain
23/01/2018 Broker: Mizuho Rating: Buy New Target: $48.0 Maintain

Resources Connection, Inc. (RECN) formed multiple top with $17.98 target or 8.00% above today’s $16.65 share price. Resources Connection, Inc. (RECN) has $524.73 million valuation. The stock decreased 0.30% or $0.05 during the last trading session, reaching $16.65. About 102,668 shares traded. Resources Connection, Inc. (NASDAQ:RECN) has risen 27.73% since June 1, 2017 and is uptrending. It has outperformed by 15.16% the S&P500.

Analysts await Resources Connection, Inc. (NASDAQ:RECN) to report earnings on July, 19. They expect $0.28 earnings per share, up 40.00% or $0.08 from last year’s $0.2 per share. RECN’s profit will be $8.82M for 14.87 P/E if the $0.28 EPS becomes a reality. After $0.18 actual earnings per share reported by Resources Connection, Inc. for the previous quarter, Wall Street now forecasts 55.56% EPS growth.

Investors sentiment increased to 1.74 in Q1 2018. Its up 0.88, from 0.86 in 2017Q4. It improved, as 4 investors sold Resources Connection, Inc. shares while 31 reduced holdings. 20 funds opened positions while 41 raised stakes. 24.45 million shares or 0.90% more from 24.23 million shares in 2017Q4 were reported. Citigroup Inc reported 40,307 shares. New York State Common Retirement Fund holds 31,100 shares or 0% of its portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) has 0% invested in Resources Connection, Inc. (NASDAQ:RECN) for 3,480 shares. Barclays Plc has 0% invested in Resources Connection, Inc. (NASDAQ:RECN). Wells Fargo Mn reported 46,417 shares. Guggenheim Limited Liability Co holds 32,983 shares. Kbc Group Inc Nv reported 32,138 shares. Fmr invested in 0% or 50,300 shares. City Hldg Com has 0% invested in Resources Connection, Inc. (NASDAQ:RECN). State Of Alaska Department Of Revenue owns 9,492 shares for 0% of their portfolio. State Of Tennessee Treasury Department, a Tennessee-based fund reported 21,292 shares. Tower Research Cap Limited Liability Corp (Trc) owns 3,723 shares. Us Fincl Bank De invested in 0% or 208 shares. Systematic Financial Management L P holds 68,309 shares or 0.02% of its portfolio. Tiaa Cref Invest Ltd Limited Liability Company owns 95,162 shares.

Since April 9, 2018, it had 0 insider purchases, and 1 sale for $95,232 activity. The insider Wargotz Michael H sold 6,200 shares worth $95,232.

Among 4 analysts covering Resources Connection Inc. (NASDAQ:RECN), 0 have Buy rating, 3 Sell and 1 Hold. Therefore 0 are positive. Resources Connection Inc. has $1700 highest and $12 lowest target. $15’s average target is -9.91% below currents $16.65 stock price. Resources Connection Inc. had 10 analyst reports since August 18, 2016 according to SRatingsIntel. The firm earned “Hold” rating on Friday, November 10 by Robert W. Baird. The rating was maintained by Deutsche Bank on Thursday, October 6 with “Sell”. Robert W. Baird maintained Resources Connection, Inc. (NASDAQ:RECN) on Wednesday, April 4 with “Hold” rating. Robert W. Baird maintained it with “Hold” rating and $15.0 target in Friday, August 25 report. The rating was downgraded by JP Morgan to “Underweight” on Thursday, January 4. The stock of Resources Connection, Inc. (NASDAQ:RECN) earned “Sell” rating by Deutsche Bank on Thursday, August 18. The firm has “Hold” rating given on Wednesday, January 3 by Robert W. Baird. On Friday, July 21 the stock rating was maintained by Deutsche Bank with “Sell”. The firm has “Sell” rating given on Thursday, January 4 by J.P. Morgan. The firm has “Neutral” rating by Robert W. Baird given on Thursday, October 6.

The stock decreased 0.80% or $0.23 during the last trading session, reaching $28.64. About 435,970 shares traded. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) has risen 88.75% since June 1, 2017 and is uptrending. It has outperformed by 76.18% the S&P500.

More important recent Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) news were published by: Seekingalpha.com which released: “Adamas Pharmaceuticals: Interesting Over The Long Term” on May 18, 2018, also Globenewswire.com published article titled: “Adamas Reports First Quarter 2018 Financial Results”, Nasdaq.com published: “Adamas Announces Publication of Pharmacokinetic Data for GOCOVRIâ„¢ in Clinical Pharmacokinetics” on May 24, 2018. More interesting news about Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) was released by: Seekingalpha.com and their article: “Adamas Pharmaceuticals’ (ADMS) CEO Gregory Went on Q1 2018 Results – Earnings Call Transcript” with publication date: May 04, 2018.

Resources Connection, Inc. (NASDAQ:RECN) Institutional Positions Chart